OHIO CANCER RESEARCH ASSOCIATES (EIN 311038309) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1982

Legal Domicile

Principal Officer

WILLIAM R BOGGESS

Phone

6142241127

Tax Period

2024-01-01 to 2024-12-31

OHIO CANCER RESEARCH ASSOCIATES, founded in 1982, is a small nonprofit in the Medical Research sector that reported $580K in total revenue in fiscal year 2024. Revenue decreased 20% compared to the prior year. Expenses of $645K exceeded revenue, resulting in a 11% operating deficit.

Mission

OCR IS DEDICATED TO THE CURE AND PREVENTION OF CANCER BY PROVIDING FOUNDATIONAL SEED MONEY FOR NEW RESEARCH IDEAS.OVER 8 MILLION IN GRANTS HAS GENERATED OVER 1 BILLION FROM OTHER SOURCES BASED ON PROJECT SUCCESS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $495,561

Program Service Revenue $0

Investment Income $13,903

Other Revenue $70,850

TOTAL REVENUE $580,314

Expense Breakdown

Grants Paid $240,000

Salaries & Benefits $277,837

Fundraising Expenses $64,904

Program Expenses $529,751

Other Expenses $127,018

TOTAL EXPENSES $644,855

Year-over-Year Comparison

	2024	2023	Change
Revenue	$580,314	$725,256	-0.2%
Expenses	$644,855	$589,826	+0.1%
Net Income	$-64,541	$135,430	-1.5%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$168,267

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GRANT VARIAN MD	BOARD CHAIRM	0.50	Officer Director	$0	$0	$0
DEBORAH PARRIS PHD	PRESIDENT	0.50	Officer Director	$0	$0	$0
SUSAN COLE PHD	BOARD MEMBER	0.50	Director	$0	$0	$0
JOHN KESSLER	BOARD MEMBER	0.50	Director	$0	$0	$0
LYNN ELLIOTT	BOARD MEMBER	0.50	Director	$0	$0	$0
WILLIAM R BOGGESS	EXECUTIVE DI	40.00	Director	$123,188	$45,079	$168,267
JUSTIN LATHIA	BOARD MEMBER	0.50	Director	$0	$0	$0
MATTHEW SUMMERS	BOARD MEMBER	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$580,314	$644,855	$582,004	$-64,541
2023	$725,256	$589,826	$610,340	$135,430
2022	$601,399	$481,857	$366,928	$119,542
2021	$836,728	$522,350	$302,143	$314,378
2020	$493,852	$514,703	$167,988	$-20,851
2019	$759,673	$557,183	$127,659	$202,490
2018	$856,947	$756,113	$56,083	$100,834

OHIO CANCER RESEARCH ASSOCIATES